Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Eyepoint Pharmaceuticals Inc (EYPT)

Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Mon Nov 18, 6:00AM CST

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals: Q3 Earnings Snapshot AP - Thu Nov 7, 6:37AM CST

EyePoint Pharmaceuticals: Q3 Earnings Snapshot

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments GlobeNewswire - Thu Nov 7, 6:00AM CST

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire - Mon Nov 4, 6:00AM CST

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares GlobeNewswire - Thu Oct 31, 3:00PM CDT

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering GlobeNewswire - Tue Oct 29, 8:47PM CDT

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire - Mon Oct 28, 4:14PM CDT

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema GlobeNewswire - Mon Oct 28, 6:00AM CDT

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration GlobeNewswire - Thu Oct 24, 6:00AM CDT

EYPT : 8.95 (+7.19%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Wed Oct 16, 6:00AM CDT

EYPT : 8.95 (+7.19%)

Barchart Exclusives

Thanksgiving, GDP and Other Key Things to Watch This Week Barchart - 9 minutes ago
This week is a short week with the holiday, but there are still plenty of things to watch on the news front. In addition, there is increasing tension overseas again as the Russia/Ukraine conflict appears to be getting more intense. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot